openPR Logo
Press release

Plasma Fractionation Market is Expected to Show a favourable Growth during the Forecast Period 2021-2025

07-07-2021 08:16 PM CET | Health & Medicine

Press release from: Fairfield Market Research

Plasma-derived medical products have been used for decades to treat clinical diseases. Even though there are more than 30 plasma-derived medications, they are in short supply making them expensive. Several plasma protein concentrates such as gamma globulin to treat immunodeficiency and clotting factor concentrates to treat haemophilia are considered essential medicines by the WHO, ensuring bright prospects for the overall plasma fractionation market.

Get PDF Sample Copy of this Report (Including Full TOC, List of Tables & Figures) :
https://www.fairfieldmarketresearch.com/report/plasma-fractionation-market/

Lack of Treatment of Haemophilia Makes Plasma Fractionation the Need of the Hour

WHO data suggests a wide chasm between the demand and supply of essential plasma products to treat different ailments. The World Federation of Haemophilia believes only a third of patients with haemophilia A or B are actually diagnosed and approx. a quarter receive proper treatment. In addition, less than a tenth of patients with primary immune deficiency are diagnosed and even less receive treatment. The WHO is seeking the implementation of GMP in blood establishments through the WHO Expert Committee on Biological Standardization to aid enhancement of NRA’s in the sector.

Protease Inhibitors Unlikely to Outpace Immunoglobin Segment in Plasma Fractionation Market

Immunoglobins accounted for the largest segment of the plasma fractionation market in 2019 as it is a popular treatment option in autoimmune and neurological conditions. Immunoglobins are used to treat chronic inflammatory demyelinating polyradiculoneuropathy and primary immune deficiencies. There has been a spike in the diagnostic rate of immune diseases recently due to massive investments in immunodeficiency research. Nonetheless, the protease inhibitor segment should record the highest growth rate during the forecast period, primarily as an antiviral agent. Increasing outbreaks of viruses such as SARS, MERS, and COVID-19 are anticipated to benefit demand for protease inhibitors in the plasma fractionation market.

Intense Competition And Product Launches Characterize Plasma Fractionation Market

Major companies in the plasma fractionation market are establishing dedicated plasma production units. For e.g. – Israeli biotech company Alishech has installed the largest blood plasma fractionation unit in Russia that will manufacture more than 25 types of dried plasma and drugs. In the US, Kendrion Biopharma received FDA authorization to setup a plasma production facility in the state of New York. Other players of note in the plasma fractionation market include CSL, Grifols, Shire, Octapharma, Kedrion, LFB , Biotest, Sanquin, China Biologic Products, Bio Products Laboratory, Japan Blood Products Organization, Green Cross Corporation, Shanghai RAAS Blood Products , Emergent BioSolutions , Intas Biopharmaceuticals , Bharat Serums and Vaccines Limited , SK Plasma, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., KabaFusion , and Centurion Pharma.

In Order to place the Purchase Query Click Here: sales@fairfieldmarketresearch.com

Convalescent Plasma Therapy Could be the Saving Grace for COVID-19 Affected Patients

COVID-19 has turned the global economy upside down and pharma companies and healthcare providers have been racing to develop treatments to target the novel variants of this infectious disease. Even though no specific drugs are currently on the horizon, convalescent plasma (CP) therapy has been encouraging in clinical trials of COVID-19 patients. Nodal agencies are now offering CP to their patients as clinical investigations on their safety and efficacy are underway. While CP has not been approved by the US FDA to treat COVID-19, it is regulated as an investigational product under emergency authorization for COVID-19 patients. Thus, the true impact of COVID-19 on the plasma fractionation market would largely depend on the outcome of the ongoing clinical trials.

Browse Our Latest Reports: https://www.fairfieldmarketresearch.com/shop/

Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: mail@fairfieldmarketresearch.com
Follow us on LinkedIn: https://bit.ly/3voYIm9

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Fractionation Market is Expected to Show a favourable Growth during the Forecast Period 2021-2025 here

News-ID: 2323642 • Views: 276

More Releases from Fairfield Market Research

Double-digit Growth on the Anvil in Asia-Pacific Yacht Charter Market, States Fa …
The global yacht charter market is driven by an upsurge in leisure activities as consumers across demographics discover the pleasure of yachting to exotic locations. Charter yachts are immensely popular as they rival the best that luxury hotels have to offer with the added advantage of complete seclusion as any tourists can travel to a waterbody of their choice. Tourists can visit several locations in a single trip and avoid
Microbial Fuel Cell (MFC) Market Will be Worth US $15.59 Mn by 2025, Registering …
The global microbial fuel cell (MFC) market is expected to cross the growth threshold required for competitors to make lucrative gains. The total worth of the global microbial fuel cell (MFC) market is expected to supplant US $15 Mn by the end of 2025, growing at a stupendous CAGR of 9.8% during the period between 2021 and 2025. The wide spectrum of applications pertaining to microbial fuel cells is the
Global Graphite Market Poised for a Robust 8.5% CAGR for by 2025; Steelmaking, a …
One of the most desirable materials among those active in the next-generation energy sector, graphite represents a rapidly progressing, multi-billion-dollar market at a global level. Majorly fuelled by the advent of renewable energy sources, and innovations in green energy technologies, Fairfield Market Research expects the global graphite market to see a robust growth outlook during 2021 – 2025. A new report by the company forecasts a strong 8.5% CAGR for
Global Toothpaste Tablet Market to Remain Afloat as Green Practices of Personal …
Sale of toothpaste tablets is gaining momentum as a large section of the global population gravitates towards following staunch standards of personal hygiene. The global value of the toothpaste tablet market is estimated to touch US$152.3 Mn by 2026, growing at a robust CAGR of 6.8% during the period between 2021 and 2026. The past decade has witnessed a heavy uptick in advertising budgets of personal care products. This has

All 5 Releases


More Releases for Bio

Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are
Bio Simulation Technology Market
Global Bio Simulation Technology Industry Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the
Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021
Qyresearchreports include new market research report “Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021″ to its huge collection of research reports. This market intelligence report serves its readers with an executive-level blueprint of the global Bio-Polyethylene Terephthalate (Bio-PET) market. Data from a number of paid and unpaid sources including press releases, journals, presentations, and white papers has been taken into account for collating this report. The various factors influencing the growth of
SHANE RADBONE CORPORATE BIO
Young, dynamic and highly successful Shane founded his own business, Executive Fitness Management at age 20 in 1991. After a successful career in football that took him as high as playing for Essendon, Shane appreciated the need to have more than just sport in his portfolio. However taking his on field attitude to the corporate arena, Executive Fitness Management (EFM) grew into Australia’s largest Corporate Fitness Company. It started with
The Bio-Chromatographers’ wish
Simply high dynamic binding capacities (DBC’s) are no longer sufficient. High DBC, at high flow rates with close to 100% recovery, across a wide range of molecular weights, this is what chromatographers look for in modern ion exchange resins. “BioPro” YMC’s hugely successful ion exchange material offers exactly this. The growing user base confirms very good separation, high dynamic binding capacities and excellent recoveries for the anion as well as